Comparing the Effects of Hydroxy Ethyl Starch 6% and Gelatin as Replacement for Prime during Coronary Artery Bypass Graft Surgery

Document Type : Original Article (s)

Authors

1 Associate Professor, Department of Anesthesiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Student of Medicine, School of Medicine AND Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Ira

3 Associate Professor, Department of Community Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Several fluids have been used in priming the cardiopulmonary pump in coronary artery bypass graft surgery (CABG). Hydroxy-ethyl starch 6% (HES 6%) is a new colloid fluid which is widely used as a substitute for intraoperative fluid. Gelatin is also a commonly used colloid fluid for priming. However, it has some adverse effects, especially on the coagulation system.Methods: In this clinical trial, patients were randomized into two groups of HES 6% and gelatin. Prothrombin time (PT), partial thromboplastin time (PTT), and international normalized ratio (INR) were measured before surgery and immediately and 24 hours after the operation. Chest drainage (CD) was measured 24 hours after the operation. Urine output (UO) was measured during the first 24 postoperative hours. Blood urea nitrogen (BUN) and creatinine were measured before and 24 hours after surgery. Data was analyzed with SPSS.Findings: CD, INR, PT, and UO were not significantly different between HES 6% and gelatin groups. PTT was significantly higher in gelatin group only at the end of the surgery (56 ± 35 vs. 44 ± 27). BUN was only significantly higher in HES group 24 hours after surgery (19.9 ± 9.8 vs. 16.4 ± 7.6). Creatinine, sodium, and potassium concentrations did not differ at any time.Conclusion: HES and gelatin are both options for prime in cardiopulmonary pump. They have adverse effects on renal function and coagulation. More studies with larger sample size are recommended to clarify their advantages.

Keywords

References

  1. Kozek-Langenecker SA, Jungheinrich C, Sauermann W, Van der Linden P. The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trials. Anesth Analg 2008; 107(2): 382-90.
  2. Boldt J. Modern rapidly degradable hydroxyethyl starches: current concepts. Anesth Analg 2009; 108(5): 1574-82.
  3. Gandhi SD, Weiskopf RB, Jungheinrich C, Koorn R, Miller D, Shangraw RE, et al. Volume replacement therapy during major orthopedic surgery using Voluven (hydroxyethyl starch 130/0.4) or hetastarch. Anesthesiology 2007; 106(6): 1120-7.
  4. Boldt J, Brosch C, Ducke M, Papsdorf M, Lehmann A. Influence of volume therapy with a modern hydroxyethylstarch preparation on kidney function in cardiac surgery patients with compromised renal function: a comparison with human albumin. Crit Care Med 2007; 35(12): 2740-6.
  5. Boldt J, Brosch C, Rohm K, Papsdorf M, Mengistu A. Comparison of the effects of gelatin and a modern hydroxyethyl starch solution on renal function and inflammatory response in elderly cardiac surgery patients. Br J Anaesth 2008; 100(4): 457-64.
  6. Hanart C, Khalife M, De VA, Otte F, De HS, Van der Linden P. Perioperative volume replacement in children undergoing cardiac surgery: albumin versus hydroxyethyl starch 130/0.4. Crit Care Med 2009; 37(2): 696-701.
  7. Hartog C, Reinhart K. CONTRA: Hydroxyethyl starch solutions are unsafe in critically ill patients. Intensive Care Med 2009; 35(8): 1337-42.
  8. Standl T, Lochbuehler H, Galli C, Reich A, Dietrich G, Hagemann H. HES 130/0.4 (Voluven) or human albumin in children younger than 2 yr undergoing non-cardiac surgery. A prospective, randomized, open label, multicentre trial. Eur J Anaesthesiol 2008; 25(6): 437-45.
  9. Witt L, Osthaus WA, Juttner B, Heimbucher C, Sumpelmann R. Alteration of anion gap and strong ion difference caused by hydroxyethyl starch 6% (130/0.42) and gelatin 4% in children. Paediatr Anaesth 2008; 18(10): 934-9.
  10. Schabinski F, Oishi J, Tuche F, Luy A, Sakr Y, Bredle D, et al. Effects of a predominantly hydroxyethyl starch (HES)-based and a predominantly non HES-based fluid therapy on renal function in surgical ICU patients. Intensive Care Med 2009; 35(9): 1539-47.
  11. Mahmood A, Gosling P, Vohra RK. Randomized clinical trial comparing the effects on renal function of hydroxyethyl starch or gelatine during aortic aneurysm surgery. Br J Surg 2007; 94(4): 427-33.
  12. Westphal M, James MF, Kozek-Langenecker S, Stocker R, Guidet B, Van AH. Hydroxyethyl starches: different products--different effects. Anesthesiology 2009; 111(1): 187-202.
  13. Davidson IJ. Acute kidney injury by hydroxyethyl starch: Can the risks be mitigated?. Crit Care Med 2009; 37(4): 1499-501.
  14. Hanna BD. How possibly are we to choose albumin or hydroxyethyl starch?. Crit Care Med 2009; 37(2): 788-9.
  15. Boldt J. PRO: hydroxyethylstarch can be safely used in the intensive care patient--the renal debate. Intensive Care Med 2009; 35(8): 1331-6.
  16. Godet G, Lehot JJ, Janvier G, Steib A, De C, V, Coriat P. Safety of HES 130/0.4 (Voluven(R)) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial. Eur J Anaesthesiol 2008; 25(12): 986-94.
  17. Standl T, Lochbuehler H, Galli C, Reich A, Dietrich G, Hagemann H. HES 130/0.4 (Voluven) or human albumin in children younger than 2 yr undergoing non-cardiac surgery. A prospective, randomized, open label, multicentre trial. Eur J Anaesthesiol 2008; 25(6): 437-45.
  18. Ando Y, Terao Y, Fukusaki M, Yamashita K, Takada M, Tanabe T, et al. Influence of low-molecular-weight hydroxyethyl starch on microvascular permeability in patients undergoing abdominal surgery: comparison with crystalloid. J Anesth 2008; 22(4): 391-6.
  19. Wiedermann CJ. Kidney damage by hydroxyethyl starch of lower molecular weight and substitution. Eur J Anaesthesiol 2009; 26(1): 83-4.
  20. Osthaus WA, Witt L, Johanning K, Boethig D, Winterhalter M, Huber D, et al. Equal effects of gelatin and hydroxyethyl starch (6% HES 130/0.42) on modified thrombelastography in children. Acta Anaesthesiol Scand 2009; 53(3): 305-10.
  21. Vanhoonacker J, Ongenae M, Vanoverschelde H, Donadoni R. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for cardiopulmonary bypass priming: the effects on postoperative bleeding and volume expansion needs after elective CABG. Acta Anaesthesiol Belg 2009; 60(2): 91-7.
  22. Schramko AA, Suojaranta-Ylinen RT, Kuitunen AH, Kukkonen SI, Niemi TT. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial. Anesth Analg 2009; 108(1): 30-6.
  23. Raja SG, Akhtar S, Shahbaz Y, Masood A. In cardiac surgery patients does Voluven(R) impair coagulation less than other colloids? Interact Cardiovasc Thorac Surg 2011; 12(6): 1022-7.
  24. Sumpelmann R, Kretz FJ, Gabler R, Luntzer R, Baroncini S, Osterkorn D, et al. Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement in children: preliminary results of a European Prospective Multicenter Observational Postauthorization Safety Study (PASS). Paediatr Anaesth 2008; 18(10): 929-33.
  25. Boks RH, Wijers MJ, Hofland J, Takkenberg JJ, Bogers AJ. Low molecular starch versus gelatin plasma expander during CPB: does it make a difference? Perfusion 2007; 22(5): 333-7.
  26. Neuhaus W, Schick MA, Bruno RR, Schneiker B, Forster CY, Roewer N, et al. The effects of colloid solutions on renal proximal tubular cells in vitro. Anesth Analg 2012; 114(2): 371-4.
  27. Salomonowitz E, Frank W, Youssefzadeh S. Better evaluability of post-therapeutic mammograms using a double-exposure technic. A prospective perception study Rofo 1990; 152(5): 574-6. [In Russian].
Journal of Isfahan Medical School
Volume 31, Issue 223 - Serial Number 223
January and February 2013
Pages 16-24

Files

History

  • Receive Date: 21 July 2012
  • Revise Date: 01 November 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics